Board MeetingCENTRALPHL
CENTRALPHL Board to Review Q2 Results for FY 2023–24 on 7 February 2024
Announcement summary
- What happened
- CENTRALPHL will hold a board meeting on 7 February 2024 at 3:30 PM to review unaudited financial statements for Q2 of FY 2023–24.
- Meeting date
- 7 February 2024
- Meeting time
- 3:30 PM
- Purpose
- consider audited financial statements
- Financial period
- Q2
- Financial year
- FY 2023–24
- Company
- Central Pharmaceuticals Limited
- Announcement published
Original announcement
The Company has further informed that due to unavoidable circumstances the meeting of the Board of Directors of the Company as per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on February 07, 2024 at 3:30 PM instead of January 31, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2023.
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 65bb1e84edb49c4b75aa02f5
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from CENTRALPHL
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.